| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 05/30/2013 | WO2013077821A1 Homogeneous biguanide composition |
| 05/30/2013 | WO2013077820A1 Treatment package composed of dosage forms comprising nateglinide -metformin hydrochloride |
| 05/30/2013 | WO2013077819A1 Pharmaceutical formulations comprising nateglinide |
| 05/30/2013 | WO2013077815A1 Imatinib solid dosage forms reconstituted just before use |
| 05/30/2013 | WO2013077814A2 Natural-killer/t-cell lymphoma (nktcl) susceptibility prediction, diagnosis and therapy |
| 05/30/2013 | WO2013077719A1 Novel molecule obtained from krameria cytisoid es, having an anti-inflammatory effect, and method for obtaining same |
| 05/30/2013 | WO2013077709A1 Pharmaceutical composition for preventing or treating restenosis comprising epidithiodioxopiperazine compounds or derivatives thereof, or pharmaceutically acceptable salts thereof |
| 05/30/2013 | WO2013077617A1 Composition for preventing, treating or alleviating atopic dermatitis comprising immunosuppressant and transglutaminase 2 inhibitor |
| 05/30/2013 | WO2013077579A1 Pharmaceutical composition for preventing and treating ophthalmic disorders |
| 05/30/2013 | WO2013077574A1 Topical composition containing theanine derivatives for use on skin |
| 05/30/2013 | WO2013077553A1 Composition for alleviating hypoglycemia |
| 05/30/2013 | WO2013077533A1 Chewable sildenafil citrate tablets in which bitterness is masked, and production method therefor |
| 05/30/2013 | WO2013077446A1 Single-stranded nucleic acid molecule for regulating expression of gene |
| 05/30/2013 | WO2013077433A1 Keratoconjunctival protecting agent, or keratoconjunctival disorder inhibiting agent |
| 05/30/2013 | WO2013077414A1 Pharmaceutical composition useful for adhesion prevention or hemostasis |
| 05/30/2013 | WO2013077228A1 Impdh inhibitor having microrna as active component |
| 05/30/2013 | WO2013077186A1 Activity modulator, medicinal agent comprising same, use of cd300a gene-deficient mouse, and anti-cd300a antibody |
| 05/30/2013 | WO2013076659A1 Aprepitant l-proline solvates - compositions and cocrystals |
| 05/30/2013 | WO2013076646A1 A new diaza-benzofluoranthene derivative as drug |
| 05/30/2013 | WO2013076590A1 Benzothiazine compounds as h3 receptor ligands |
| 05/30/2013 | WO2013076516A1 1,4- dihydropyridine derivatives with hsp modulating activity |
| 05/30/2013 | WO2013076487A1 Phytocannabinoids for use in the treatment of intestinal inflammatory diseases |
| 05/30/2013 | WO2013076471A1 Tetrahydrocannabivarin (thcv) for use in the protection of pancreatic islet cells |
| 05/30/2013 | WO2013076339A1 Combined preparations and compositions for the treatment of fibromyalgia |
| 05/30/2013 | WO2013076275A1 Androgen receptor ligands |
| 05/30/2013 | WO2013076245A1 Allogeneic immune response control |
| 05/30/2013 | WO2013076231A1 Use of fluopyram for controlling endoparasites |
| 05/30/2013 | WO2013076230A1 Use of aryl and hetaryl carboxamides as endoparasiticides |
| 05/30/2013 | WO2013076216A1 Controlled release particles comprising dimethyl fumarate |
| 05/30/2013 | WO2013076182A1 [1, 2, 3]triazolo [4, 5 -d] pyrimidine derivatives as agonists of the cannabinoid receptor 2 agonists |
| 05/30/2013 | WO2013076179A1 Sodium salt of (r)-3-[6-amino-pyridin-3-yl]-2-(1-cyclohexyl-1h-imidazol-4-yl)-propionic acid |
| 05/30/2013 | WO2013076178A1 Crystalline salts of r)-3-[6-amino-pyridin-3-yl]-2-(1-cyclohexyl-1h-imidazol-4-yl)-propionic acid |
| 05/30/2013 | WO2013076177A1 Salt of (r)-3-(6-amino-pyridin-3-yl)-2-(1-cyclohexyl-1h-imidazol-4-yl) ethyl propionate |
| 05/30/2013 | WO2013076170A1 2-[(3,5-difluoro-3'-methoxy-1,1'-biphenyl-4-yl)amino]nicotinic acid for the treatment of psoriasis |
| 05/30/2013 | WO2013076169A1 Antibacterial tylosin derivatives and methods for their preparation |
| 05/30/2013 | WO2013076168A1 Method for producing substituted 5-fluoro-1h-pyrazolopyridines |
| 05/30/2013 | WO2013076162A1 Formulations useful in the treatment of osteoarticular diseases |
| 05/30/2013 | WO2013076160A1 Sustained release formulations useful in the treatment of diseases |
| 05/30/2013 | WO2013076121A1 Pharmaceutical composition comprising myo-inositol and d-chiro-inositol |
| 05/30/2013 | WO2013076090A1 3-phenyl-isoquinolin-1(2h)-one derivatives as parp-1 inhibitors |
| 05/30/2013 | WO2013076088A1 Device for preventing and/or treating urinary tract infections |
| 05/30/2013 | WO2013076063A1 Novel pyrrolidine derivatives as inhibitors of cathepsin |
| 05/30/2013 | WO2013075823A1 Transdermal therapeutic system comprising rotigotine and crystallization inhibitor |
| 05/30/2013 | WO2013075822A1 Transdermal therapeutic system (tts) with rotigotine |
| 05/30/2013 | WO2013075785A1 3-cyanaryl-1h-pyrazolo[2.3-b]pyridine derivatives |
| 05/30/2013 | WO2013075680A1 A method for the preparation and isolation of salts of vardenafil with acids |
| 05/30/2013 | WO2013075624A1 Glycine reuptake inhibitor and use thereof |
| 05/30/2013 | WO2013075621A1 Norepinephrine and selective serotonin receptor blocker and use thereof |
| 05/30/2013 | WO2013075607A1 Novel use of chlorogenic acid against cancer |
| 05/30/2013 | WO2013075596A1 Pentabasic dihydrogen heterocyclic ketone derivative as dhodh inhibitor and use thereof |
| 05/30/2013 | WO2013075510A1 L-setastine hydrochloride and preparation method therefor |
| 05/30/2013 | WO2013075459A1 Use of levo-oxiracetam and oxiracetam in preparation of medicines for preventing or treating coma |
| 05/30/2013 | WO2013075399A1 Unsaturated 5-membered benzo-heterocyclic compound or pharmaceutical salts thereof, and preparation method, pharmaceutical composition and use thereof |
| 05/30/2013 | WO2013075394A1 Drug carrier with chelating composite micell and use thereof |
| 05/30/2013 | WO2013075333A1 New use of neohesperidin |
| 05/30/2013 | WO2013075253A1 Thiosulfinate antioxidants and methods of use thereof |
| 05/30/2013 | WO2013075244A1 Peptide sequence design and use thereof for peptide-mediated sirna delivery |
| 05/30/2013 | WO2013075233A1 Method for treating brain cancer |
| 05/30/2013 | WO2013075227A1 β-GLUCOCEREBROSIDASE CHAPERONES |
| 05/30/2013 | WO2013075199A1 Acyl-hydrazone and oxadiazole compounds, pharmaceutical compositions containing the same and uses thereof |
| 05/30/2013 | WO2013075186A1 Polymeric nanospheres coated with chitosan folate and use of the same |
| 05/30/2013 | WO2013075176A1 Compositions and methods for modulating uterine contractions |
| 05/30/2013 | WO2013075172A1 Improved synergistic anti-diabetic compositions |
| 05/30/2013 | WO2013056245A3 Stearate compounds |
| 05/30/2013 | WO2013050539A3 Tamper-resistant oral pharmaceutical dosage form comprising opioid agonist and opioid antagonist |
| 05/30/2013 | WO2013049407A3 Anti-viral compounds |
| 05/30/2013 | WO2013049365A3 Selective metabolic approach to increasing oral bioavailability of phenylephrine and other phenolic bioactives |
| 05/30/2013 | WO2013049280A3 Sphingosine analogs, compositions, and methods related thereto |
| 05/30/2013 | WO2013048584A9 Prodrugs for treating microbial infections |
| 05/30/2013 | WO2013045934A3 Compositions comprising agents that inhibit neuropilin and tolloid like 2 |
| 05/30/2013 | WO2013030702A3 Anthelmintic formulations and treatments |
| 05/30/2013 | WO2013025074A3 Anticancer or antioxidant composition containing quamoclit pennata extract or compound derived from quamoclit pennata extract |
| 05/30/2013 | WO2013023856A8 Use of a polysaccharide polymer from the seeds of the tamarind tree in protecting against tobacco-associated damages |
| 05/30/2013 | WO2013022092A9 Heptamer-type small guide nucleic acid capable of inducing apoptosis of human hematologic cancer cells |
| 05/30/2013 | WO2013014405A3 Methods of inhibiting inflammation comprising inhibiting cd63 |
| 05/30/2013 | WO2013012806A3 Protection of cells from alu-rna-induced degenereation and inhibitors for protecting cells |
| 05/30/2013 | WO2013011098A9 Imino-sugar c-glycosides, preparation and use thereof |
| 05/30/2013 | WO2013006094A3 Composition for maintaining bone health and for treating osteoarthritis and osteoarthrosis of the joints |
| 05/30/2013 | WO2012177949A3 Compositions and methods for inhibition of expression of protein c (proc) genes |
| 05/30/2013 | WO2012170952A4 Compounds for targeting drug delivery and enhancing sirna activity |
| 05/30/2013 | WO2012158962A3 Improved peptide pharmaceuticals |
| 05/30/2013 | WO2012140596A8 Glycoside derivatives and uses thereof |
| 05/30/2013 | WO2012059725A8 Peg or peg block copolymers for treating colorectal cancer |
| 05/30/2013 | US20130137976 Functional, Cross-Linked Nanostructures for Tandem Optical Imaging and Therapy |
| 05/30/2013 | US20130137876 Nitrogen-containing heterocyclic compound and pest control agent |
| 05/30/2013 | US20130137776 Method for inhibiting histone gene transcription and expression |
| 05/30/2013 | US20130137774 Methods and use of compounds that bind to her2/neu receptor complex |
| 05/30/2013 | US20130137772 Hydroxypolyamine salts |
| 05/30/2013 | US20130137771 Fatty acids for use as a medicament |
| 05/30/2013 | US20130137770 Intravenous omega-3 fatty acid compositions & method of use |
| 05/30/2013 | US20130137769 Injectable Preparations Of Diclofenac And Its Pharmaceutically Acceptable Salts |
| 05/30/2013 | US20130137767 Methods and Compositions for Treating Arthritis with Docosahexaenoic Acid |
| 05/30/2013 | US20130137766 Compound Used to Prevent Diseases Caused by Aquaporin Deficiency |
| 05/30/2013 | US20130137765 Use of nitrooxyderivative of drug for the treatment of muscular dystrophies |
| 05/30/2013 | US20130137764 Treatment of Sleep-Wake Disorders |
| 05/30/2013 | US20130137763 Fused cyclooctyne compounds and their use in metal-free click reactions |
| 05/30/2013 | US20130137762 Composition for treating neurodegenerative disease or neuropathological condition |
| 05/30/2013 | US20130137759 Compositions and methods for treating parasitic disease |
| 05/30/2013 | US20130137758 Akt activity specifically inhibiting polypeptide |
| 05/30/2013 | US20130137757 Inhibitor of influenza virus infection |